Cinctive Capital Management LP increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 21.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 173,786 shares of the company's stock after acquiring an additional 30,470 shares during the quarter. Cinctive Capital Management LP owned approximately 0.08% of Bath & Body Works worth $6,738,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently bought and sold shares of BBWI. Golden State Wealth Management LLC purchased a new stake in Bath & Body Works during the 4th quarter worth approximately $26,000. SRS Capital Advisors Inc. increased its stake in shares of Bath & Body Works by 99.7% in the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock worth $26,000 after buying an additional 329 shares during the last quarter. UMB Bank n.a. raised its holdings in Bath & Body Works by 58.8% in the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after acquiring an additional 335 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Bath & Body Works by 81.9% during the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after acquiring an additional 431 shares during the last quarter. Finally, Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works during the 3rd quarter worth $39,000. Hedge funds and other institutional investors own 95.14% of the company's stock.
Analysts Set New Price Targets
Several equities analysts have recently commented on BBWI shares. Citigroup reduced their price target on shares of Bath & Body Works from $48.00 to $36.00 and set a "buy" rating on the stock in a research report on Monday. Argus reaffirmed a "hold" rating on shares of Bath & Body Works in a report on Friday, January 10th. Cowen restated a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. JPMorgan Chase & Co. set a $47.00 target price on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Robert W. Baird lifted their price target on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a report on Friday, February 28th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $44.31.
Read Our Latest Analysis on Bath & Body Works
Bath & Body Works Trading Down 2.5 %
BBWI traded down $0.68 during trading hours on Monday, hitting $26.61. The company's stock had a trading volume of 3,711,086 shares, compared to its average volume of 4,994,848. Bath & Body Works, Inc. has a fifty-two week low of $25.32 and a fifty-two week high of $52.99. The company has a 50-day simple moving average of $34.45 and a 200 day simple moving average of $34.16. The firm has a market capitalization of $5.70 billion, a PE ratio of 6.50, a PEG ratio of 0.92 and a beta of 1.69.
Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating analysts' consensus estimates of $2.04 by $0.05. The company had revenue of $2.79 billion for the quarter, compared to analyst estimates of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 3.01%. The ex-dividend date was Friday, February 21st. Bath & Body Works's dividend payout ratio (DPR) is presently 21.98%.
Bath & Body Works announced that its Board of Directors has approved a stock buyback program on Thursday, February 27th that permits the company to buyback $500.00 million in outstanding shares. This buyback authorization permits the company to buy up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board of directors believes its shares are undervalued.
Bath & Body Works Company Profile
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Featured Stories

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.